Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Mikael Dolsten MD, PhD
Age : 59
Public asset : 12,312,301 USD
Linked companies : Pfizer Inc. - Karyopharm Therapeutics Inc
Dr. Mikael Dolsten is an Independent Director at Karyopharm Therapeutics, Inc., a President-Worldwide Research & Development at Pfizer Inc., a Member at Government-University-Industry Research Roundtable and a Member at Royal Swedish Academy of Engineering Sciences.

He is on the Board of Directors at Karyopharm Therapeutics, Inc., PhRMA Foundation and New York Academy of Sciences. Dr. Dolsten was previously employed as a Senior Vice President by Wyeth Corp., a President by Wyeth Research, a Principal by OrbiMed Advisors LLC, a Partner by OrbiMed Advisors Private Equity, an EVP, Global Head-Pharma Research & Discovery by Boehringer Ingelheim Pharmaceuticals, Inc., a Trustee by New York Hall of Science, and a Member-Benefits, Law & Regulatory Committee by Wyeth Pharmaceuticals, Inc.

He received his doctorate degree from the University of Lund.

Current positions of Mikael Dolsten MD, PhD 
NameTitle Since
Pfizer Inc.
President-Worldwide Research & Development 2009
Karyopharm Therapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2015
New York Academy of Sciences Member-Governors Board -
PhRMA Foundation Director -
Royal Swedish Academy of Engineering Sciences Member -
Government-University-Industry Research Roundtable Member -

Holdings of Mikael Dolsten MD, PhD 
Pfizer (PFE)
339,9310.0057%12,591,044 USD
Karyopharm Therapeutics Inc (KPTI)
Biotechnology & Medical Research
00.0000%0 USD

Mikael Dolsten MD, PhD: Personal Network 

Most Read News 
02/16 WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
02/17 STEVE WYNN : Top Company News of the Day
02/21 PING LI : Glencore, Lloyds lift FTSE as investors hail earnings
02/16 ROMAN ABRAMOVICH : Co-owners of Russia's Nornickel back in fight for control
02/19 PETER THIEL : Top Company News of the Day
02/16 VINCENT BOLLORÉ : Vivendi shares drop as French group's lack of guidance underwhelms
02/17 THOMAS WILSON : Japan, short of workers, eyes hiking optional pension age beyond 70
02/22 WARREN BUFFETT : Buffett letter may tout optimism as broader market worries ebb
02/19 OLEG DERIPASKA : Deripaska to Step Down as President of EN+ and Rusal -FT
02/20 RUPERT MURDOCH : Murdoch's Fox seeks to win bid approval by extending Sky News guarantee
More news

© 2018 People and Ownership :   
Mikael Dolsten MD, PhD : Connections 
Metamark Genetics, Inc.
Delphi Management Partners VIII LLC
Harvard Partners Center for Genetics & Genomics
National Venture Capital Association
Delphi Ventures III LP
Delphi Management Partners VII LLC
Relypsa, Inc.
Delphi Ventures, Inc.
Vicarious Surgical, Inc.

Popular Business Leaders 
Bernard Arnault Jean-michel Aulas Jeff Bezos Martin Blessing Kurt Bock Warren Buffett Jean-pierre Clamadieu Tim Cook Richard Cousins Elmar Degenhart Michael Dell Jamie Dimon Patrick Drahi Carlos Ghosn Stuart Gulliver David Henry Heinrich Hiesinger Carl Icahn Ingvar Kamprad Dara Khosrowshahi Isabelle Kocher Bruno Lafont Jack Ma Gérard Mestrallet Lakshmi Mittal Rupert Murdoch Elon Musk Michael O'leary Nelson Peltz Stefan Quandt Sumner Redstone Alexandre Ricard Stéphane Richard Wilbur Ross Eric Schmidt Charles Schwab George Soros Rupert Stadler Bernard Tapie Peter Terium Peter Thiel Patrick Thomas François Villeroy De Galhau Meg Whitman John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders